SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.125
-0.025 (-2.17%)
Sep 18, 2026, 3:54 PM HKT
SinoMab BioScience Market Cap
SinoMab BioScience has a market cap or net worth of 1.56 billion as of September 18, 2026. Its market cap has decreased by -42.60% in one year.
Market Cap
1.56B
Enterprise Value
1.63B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.13
ChartMarket Cap Chart
Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 1.56B, a decrease of -74.16%. That is a compound annual growth rate of -17.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.56B | -16.04% |
| Dec 31, 2025 | 1.86B | 56.14% |
| Dec 31, 2024 | 1.19B | -31.56% |
| Dec 29, 2023 | 1.74B | -7.18% |
| Dec 30, 2022 | 1.87B | -34.91% |
| Dec 31, 2021 | 2.88B | -37.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 1.98B |
| HighTide Therapeutics | 1.89B |
| Guangzhou Innogen Pharmaceutical Group | 1.76B |
| Mabpharm | 1.61B |
| Shandong Boan Biotechnology | 1.52B |
| Beijing Biostar Pharmaceuticals | 1.49B |
| Zhaoke Ophthalmology | 1.37B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.35B |